United States - English - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 20 mg in 1 ml - erythromycin topical solution usp, 2% is indicated for the topical treatment of acne vulgaris. erythromycin topical solution usp, 2% is contraindicated in those individuals who have shown hypersensitivity to any of its components.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

santen pharmaceutical co.,ltd. - erythromycin lactobionate; colistin sodium methanesulfonate - milky white, translucent, ophthalmic ointment, 3.5g, (tube) white, (cap) vivid blue

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol laboratories ltd - erythromycin - gastro-resistant tablet - 250mg

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ccd animal health pty ltd - erythromycin as the thiocyanate - oral powder, pre-mix - erythromycin as the thiocyanate antibiotic active 750.0 mg/g - antibiotic & related - poultry | breeders | broiler | chickens | chicks | chooks | day old chicks | hatchlings | layers - cholera | chronic respiratory disease complex | coryza | erythromycin susceptible infections | infectious coryza

United States - English - NLM (National Library of Medicine)

carilion materials management - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets, usp and other antibacterial drugs, erythromycin tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. erythromycin tablets, usp are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the diseases listed below: upper respiratory tract infections of mild to moderate degree caused by streptococcus pyogenes ; streptococcus pneumoniae ; haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of h. influenzae are not susceptible to the erythromycin concentrations

United States - English - NLM (National Library of Medicine)

a-s medication solutions - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets, usp and other antibacterial drugs, erythromycin tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. erythromycin tablets, usp are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the diseases listed below: upper respiratory tract infections of mild to moderate degree caused by streptococcus pyogenes ; streptococcus pneumoniae ; haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of h. influenzae are not susceptible to the erythromycin concentrations

United States - English - NLM (National Library of Medicine)

e. fougera & co. - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - solution - 20 mg - erythromycin pledgets, usp are indicated for the topical treatment of acne vulgaris. erythromycin pledgets, usp are contraindicated in those individuals who have shown hypersensitivity to any of its components.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

panpharma uk ltd - erythromycin lactobionate - powder for solution for infusion - 1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - erythromycin - gastro-resistant tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

almus pharmaceuticals ltd - erythromycin - gastro-resistant tablet - 250mg